VMP 42355211000001107

Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants

Name Mesalazine 1g suppositories
BNF code 0105010B0AAAJAJ
Virtual Therapeutic Moiety Mesalazine
Date identifier became valid 20 Oct 2023
Previous product identifier 317408008
Basis of preferred name rINN - Recommended International Non-proprietary
Prescribing status Valid as a prescribable product
Sugar free
Gluten free
Preservative free
CFC free
Dose form Discrete
Unit dose form size 1.000
Unit dose form units suppository
Unit dose unit of measure suppository
Virtual Product Ingredient
Ingredient Mesalazine
Basis of pharmaceutical strength Based on Ingredient Substance
Strength value numerator 1.000
Strength value numerator unit gram
Ontology Drug Form & Route
Form & Route suppository.rectal
Dose Form
Formulation Suppository
Drug Route
Route Rectal
Controlled Drug Prescribing Information
Controlled Drug category No Controlled Drug Status
Actual Medicinal Products
Octasa 1g suppositories (Tillotts Pharma UK Ltd)
Pentasa 1g suppositories (CST Pharma Ltd)
Pentasa 1g suppositories (Ferring Pharmaceuticals Ltd)
Pentasa 1g suppositories (Pharmaram Ltd)
Pentasa 1g suppositories (Sigma Pharmaceuticals Plc)
Salofalk 1g suppositories (Dr. Falk Pharma UK Ltd)
Virtual Medicinal Product Packs
Mesalazine 1g suppositories 10 suppository
Mesalazine 1g suppositories 28 suppository
Mesalazine 1g suppositories 30 suppository

dm+d data retrieved from TRUD: release NHSBSA_4.3.0_20240422000001, imported on 22nd April 2024 at 05:06:50.

Feedback